| Dr Iris Chambliss Kelly, MD | |
|
657 Hemlock St, Suite 220, Macon, GA 31201-8329 | |
| (478) 741-7241 | |
| (478) 745-8932 |
| Full Name | Dr Iris Chambliss Kelly |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 657 Hemlock St, Macon, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134172588 | NPI | - | NPPES |
| 5562814 | Other | SC | CIGNA |
| 57-6007863095 | Other | SC | BCBS OF SC |
| 230707 | Medicaid | SC | |
| 57-6007863071 | Other | SC | BLUE CHOICE OF SC |
| 7649442 | Other | SC | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 23070 (South Carolina) | Secondary |
| 208M00000X | Hospitalist | 51448 (Georgia) | Secondary |
| 207R00000X | Internal Medicine | 051488 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Redmond Regional Medical Center | Rome, GA | Hospital |
| Memorial University Medical Center | Savannah, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of Georgia Pc | 2961483607 | 255 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System In Waycross, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154745982 PECOS PAC ID: 0042124919 Enrollment ID: O20040308000639 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20040527000856 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | Magna Care Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487002382 PECOS PAC ID: 9638463003 Enrollment ID: O20160808001242 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Entity Name | Houston Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962040147 PECOS PAC ID: 2769813906 Enrollment ID: O20200504000786 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Iris Chambliss Kelly, MD 657 Hemlock St, Suite 220, Macon, GA 31201-8329 Ph: (478) 741-7241 | Dr Iris Chambliss Kelly, MD 657 Hemlock St, Suite 220, Macon, GA 31201-8329 Ph: (478) 741-7241 |
News Archive
In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes' ability to smell and target their victims.
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has initiated a first-in-human, proof-of-concept study evaluating the safety, tolerability, persistence and histological effects of ATX-104, a light-activated facial contouring agent.
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
› Verified 1 days ago
Mrs. Mary E Mckinley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr, Suite 110, Macon, GA 31217 Phone: 478-841-2707 Fax: 478-841-2708 | |
Dr. Swathi Singanamala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Martin Luther King Jr Blvd, Suite 200, Macon, GA 31201 Phone: 478-745-5455 Fax: 478-803-5232 | |
Dr. Sebastian Alan Montgomery, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Dr Ste 430, Macon, GA 31217 Phone: 478-751-0480 | |
Sagar Jayant Panse, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 2nd St, Suite 201, Macon, GA 31201 Phone: 478-745-4322 Fax: 478-750-8789 | |
Dr. Rana K Munna, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Preston Ct, Macon, GA 31210 Phone: 478-238-0771 Fax: 478-238-6688 | |
Oliver Wendell Horne Iv, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1062 Forsyth St Ste 1b, Macon, GA 31201 Phone: 478-741-1208 | |
Thomas P Meyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr Bldg D, Suite 200, Macon, GA 31217 Phone: 478-745-5476 Fax: 478-745-3768 |